ALB
NYSE · Chemicals
Albemarle Corp
$203.52
+5.17 (+2.61%)
Financial Highlights (FY 2026)
Revenue
5.00B
Net Income
-496,146,693
Gross Margin
13.1%
Profit Margin
-9.9%
Rev Growth
-11.1%
D/E Ratio
0.34
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 13.1% | 13.1% | 38.2% | 38.2% |
| Operating Margin | -7.1% | -6.4% | 19.2% | 18.7% |
| Profit Margin | -9.9% | -9.4% | 12.9% | 14.3% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 5.00B | 5.62B | 6.60B | 5.82B |
| Gross Profit | 654.59M | 736.33M | 2.52B | 2.23B |
| Operating Income | -356,278,756 | -360,687,154 | 1.27B | 1.09B |
| Net Income | -496,146,693 | -502,285,740 | 847.75M | 834.74M |
| Gross Margin | 13.1% | 13.1% | 38.2% | 38.2% |
| Operating Margin | -7.1% | -6.4% | 19.2% | 18.7% |
| Profit Margin | -9.9% | -9.4% | 12.9% | 14.3% |
| Rev Growth | -11.1% | -11.1% | +5.0% | +9.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 2.92B | 2.92B | 2.54B | 2.67B |
| Total Equity | 8.71B | 8.71B | 6.30B | 6.09B |
| D/E Ratio | 0.34 | 0.34 | 0.40 | 0.44 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 294.56M | 314.78M | 1.64B | 1.66B |
| Free Cash Flow | — | — | 929.19M | 1.04B |